PMID: 12756209May 21, 2003Paper

The effect of incubation conditions on the enzyme kinetics of udp-glucuronosyltransferases

Drug Metabolism and Disposition : the Biological Fate of Chemicals
Matthew G SoarsSteven A Wrighton

Abstract

Traditionally, the Michaelis-Menten equation has been used to determine kinetic parameters for in vitro glucuronidation assays. Recently, estradiol-3-glucuronide formation was shown to exhibit non-Michaelis-Menten kinetics consistent with autoactivation. A concern with the observation of nontraditional kinetics is that they may result as an artifact of the incubation conditions. To examine this concern, the formation of estradiol-3-glucuronide was investigated using human liver microsomes prepared by two different methods, a range of assay conditions, and activation by alamethecin, sonication, or Brij 58 (polyoxyethylene monocetyl ether). Interestingly, holding the other assay components constant, estradiol-3-glucuronide formation was up to 2.5-fold greater using microsomes prepared in phosphate buffer compared with those prepared in sucrose. Incubations activated by alamethecin consistently exhibited the highest rates of estradiol glucuronidation versus the other activators. Furthermore, estradiol-3-glucuronidation exhibited autoactivation kinetics in all of the conditions investigated (n = 1.2-1.7). Nontraditional kinetics were also observed when other UGT1A1 substrates such as ethinylestradiol, buprenorphine, and anthraflavi...Continue Reading

References

Jan 15, 1987·Biochemical Pharmacology·M W CoughtrieJ R Bend
Sep 1, 1988·Journal of Steroid Biochemistry·G M Pacifici, D J Back
Jun 7, 1973·Biochimica Et Biophysica Acta·A B Graham, G C Wood
Jul 31, 1999·Artificial Cells, Blood Substitutes, and Immobilization Biotechnology·S Bruni, T M Chang
Jul 24, 2001·Current Drug Metabolism·C D KingT R Tephly
Mar 20, 2002·Drug Metabolism and Disposition : the Biological Fate of Chemicals·J Matthew Hutzler, Timothy S Tracy
Mar 22, 2002·The Journal of Pharmacology and Experimental Therapeutics·M G SoarsR J Riley
May 23, 2002·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Miki NakajimaTsuyoshi Yokoi
May 23, 2002·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Daniel C KempJeffrey C Stevens
Sep 14, 2002·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Sarvesh C VashishthaLawrence Hogg
Mar 12, 2003·Journal of Pharmacological and Toxicological Methods·Matthew G SoarsSteven A Wrighton

❮ Previous
Next ❯

Citations

Jul 13, 2005·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Mellar P Davis
Feb 3, 2009·Pharmaceutical Research·Helen E CubittAleksandra Galetin
Mar 26, 2011·Bioconjugate Chemistry·Jinda FanEvan D Kharasch
Jun 15, 2007·Pharmacogenetics and Genomics·Bertrand CaillierChantal Guillemette
Feb 4, 2010·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Hongliang CaiJeffrey C Stevens
Jan 15, 2010·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Kirsten AbildskovMarianne Garland
Oct 30, 2010·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Jin ZhouRory P Remmel
Nov 13, 2004·Breast Cancer Research : BCR·Chantal GuillemetteJohanie Lépine
Jan 29, 2014·European Journal of Drug Metabolism and Pharmacokinetics·Kohei YamamotoNobumitsu Hanioka
Apr 19, 2006·In Vitro Cellular & Developmental Biology. Animal·Qing WangJibin Li
Feb 11, 2010·Analytical and Bioanalytical Chemistry·M Teresa DonatoAgustín Lahoz
Feb 3, 2007·Expert Opinion on Drug Metabolism & Toxicology·Joseph K Ritter
Oct 13, 2009·Drug Metabolism Reviews·Yuji IshiiHideyuki Yamada
Jul 16, 2008·Expert Opinion on Drug Metabolism & Toxicology·María José Gómez-LechónMaría Teresa Donato
Jan 8, 2014·Expert Opinion on Drug Metabolism & Toxicology·Li Di
Mar 7, 2013·Drug Metabolism Reviews·Satya Prakash TripathiAbhay T Sangamwar
Dec 19, 2009·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·O F Iwuchukwu, S Nagar
Mar 16, 2011·Journal of Pharmaceutical Sciences·Michaela BöhmdorferWalter Jäger
Oct 23, 2008·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·D UngS Nagar
Jul 3, 2015·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Yuuka MiyakeNobumitsu Hanioka
Apr 21, 2010·Archives of Biochemistry and Biophysics·Hanno BotheThomas Haarmann-Stemmann
Dec 29, 2009·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·T PallmannK Bender
Mar 8, 2016·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Melanie A LaddJohn W Nichols
Feb 12, 2008·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Sébastien GagnéJean-François Lévesque
May 31, 2006·Biopharmaceutics & Drug Disposition·Yuji ManoHidetaka Kamimura
Mar 16, 2013·The Journal of Pharmacy and Pharmacology·Jin-Hui SongDe-Wei Zhao
Apr 11, 2012·Journal of Veterinary Pharmacology and Therapeutics·T EbnerJ Elliott
Aug 21, 2010·The Journal of Pharmacy and Pharmacology·Michaela MiksitsWalter Jäger
Aug 15, 2015·Chemical Research in Toxicology·Alexander T CartusDieter Schrenk

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.